Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats

Li,Bingong; Xiao,Jian; Li,Yong; Zhang,Jian; Zeng,Minghui

doi:10.3892/etm.2013.1273

Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats

Authors:
- Bingong Li
- Jian Xiao
- Yong Li
- Jian Zhang
- Minghui Zeng
View Affiliations

Affiliations: Department of Cardiology, First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 27, 2013 https://doi.org/10.3892/etm.2013.1273
Pages: 1105-1112

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neuregulin-1 (NRG-1) is a cardioactive growth factor released from endothelial cells. However, the effect of NRG-1 on ventricular remodeling in diabetic cardiomyopathy (DCM) remains unclear. The aim of the present study was to investigate the pathophysiological role of NRG-1 in a rat model of DCM. Rat cardiac microvascular endothelial cells (CMECs) were transfected with human NRG-1 (hNRG‑1) lentivirus. The hNRG-1 medium was utilized to culture rat cardiomyocytes. The cardiomyocytes were counted with a hemacytometer to determine the proliferation index and Annexin Ⅴ/propidium iodide double staining was employed to examine the apoptotic rate. A rat model of DCM was induced by an intraperitoneal injection of streptozotocin. The hNRG-1 lentivirus was injected into the myocardium of the DCM model rats. Four weeks after the lentiviral injection, cardiac catheterization was performed to evaluate the cardiac function. Apoptotic cells were determined by terminal deoxynucleotidyl transferase‑mediated dUTP nick‑end labeling (TUNEL) staining. Left ventricular sections were stained with Masson's trichrome to investigate the myocardial collagen content. The expression levels of related genes and proteins were analyzed. The results indicated that hNRG-1 conditioned medium stimulated the proliferation and counteracted the apoptosis of cardiomyocytes in vitro. In the rats with DCM, gene transfer of hNRG-1 to the myocardium improved heart function, as indicated by invasive hemodynamic measurements. In addition, hNRG-1 reduced the number of apoptotic cells, decreased the expression of bax and increased the expression of bcl-2 in the myocardium of the DCM model rats. Myocardial fibrosis and type I and III pro-collagen mRNA levels in the myocardium were significantly reduced by hNRG-1. hNRG-1 also increased the expression of phospho-Akt and phospho-eNOS in the myocardium. In conclusion, the gene transfer of hNRG-1 ameliorates cardiac dysfunction in diabetes. Although further studies are required, NRG-1 appears to protect cardiomyocytes against apoptosis and to reduce the extent of myocardial interstitial fibrosis.

View Figures

View References

1.	Acar E, Ural D, Bildirici U, et al: Diabetic cardiomyopathy. Anadolu Kardiyol Derg. 11:732–737. 2011.
2.	Battiprolu PK, Gillette TG, Wang ZV, et al: Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discov Today Dis Mech. 7:e135–e143. 2010. View Article : Google Scholar : PubMed/NCBI
3.	An D and Rodrigues B: Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 291:H1489–H1506. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Boudina S and Abel ED: Diabetic cardiomyopathy revisited. Circulation. 115:3213–3223. 2007. View Article : Google Scholar : PubMed/NCBI
5.	Hsueh W, Abel ED, Breslow JL, et al: Recipes for creating animal models of diabetic cardiovascular disease. Circ Res. 100:1415–1427. 2007. View Article : Google Scholar : PubMed/NCBI
6.	Sun D, Shen M, Li J, et al: Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol. 10:42011.PubMed/NCBI
7.	Xu Y, Li X, Liu X and Zhou M: Neuregulin-1/ErbB signaling and chronic heart failure. Adv Pharmacol. 59:31–51. 2010. View Article : Google Scholar : PubMed/NCBI
8.	Odiete O, Hill MF and Sawyer DB: Neuregulin in cardiovascular development and disease. Circ Res. 111:1376–1385. 2012. View Article : Google Scholar : PubMed/NCBI
9.	Lemmens K, Segers VF, Demolder M and De Keulenaer GW: Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk. J Biol Chem. 281:19469–19477. 2006. View Article : Google Scholar : PubMed/NCBI
10.	Cote GM, Miller TA, Lebrasseur NK, et al: Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Exp Cell Res. 311:135–146. 2005. View Article : Google Scholar : PubMed/NCBI
11.	Pentassuglia L, Timolati F, Seifriz F, et al: Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Exp Cell Res. 313:1588–1601. 2007. View Article : Google Scholar : PubMed/NCBI
12.	Pentassuglia L and Sawyer DB: The role of neuregulin 1β/ErbB signaling in the heart. Exp Cell Res. 315:627–637. 2009.
13.	Jabbour A, Hayward CS, Keogh AM, et al: Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur J Heart Fail. 13:83–92. 2011. View Article : Google Scholar
14.	Li B, Zheng Z, Wei Y, et al: Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats. Cardiovasc Diabetol. 10:692011.PubMed/NCBI
15.	Kilkenny C, Browne WJ, Cuthill IC, et al: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8:e10004122010. View Article : Google Scholar : PubMed/NCBI
16.	Wold LE and Ren J: Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase-dependent oxidative stress mechanism. Biochem Biophys Res Commun. 318:1066–1071. 2004. View Article : Google Scholar
17.	Wichi R, Malfitano C, Rosa K, et al: Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol. 6:142007. View Article : Google Scholar : PubMed/NCBI
18.	Jiang Z and Zhou M: Neuregulin signaling and heart failure. Curr Heart Fail Rep. 7:42–47. 2010. View Article : Google Scholar : PubMed/NCBI
19.	Dammann O, Bueter W, Leviton A, et al: Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology. 93:182–187. 2008. View Article : Google Scholar : PubMed/NCBI
20.	Kuramochi Y, Guo X and Sawyer DB: Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol. 41:228–235. 2006. View Article : Google Scholar : PubMed/NCBI
21.	Hertig CM, Kubalak SW, Wang Y and Chien KR: Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the phosphatidylinositol 3-kinase pathway and cardiac chamber morphogenesis. J Biol Chem. 274:37362–37369. 1999. View Article : Google Scholar : PubMed/NCBI
22.	Calvo M, Zhu N, Grist J, et al: Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. Glia. 59:554–568. 2011. View Article : Google Scholar : PubMed/NCBI
23.	Ky B, Kimmel SE, Safa RN, et al: Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation. 120:310–317. 2009. View Article : Google Scholar : PubMed/NCBI
24.	Cai L, Li W, Wang G, et al: Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes. 51:1938–1948. 2002. View Article : Google Scholar : PubMed/NCBI
25.	Mano Y, Anzai T, Kaneko H, et al: Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Circ J. 75:1717–1727. 2011. View Article : Google Scholar : PubMed/NCBI
26.	Wang B, Shravah J, Luo H, et al: Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun. 389:105–111. 2009. View Article : Google Scholar : PubMed/NCBI
27.	Markou T, Barlaka E, Bartucci M and Lazou A: Signal transduction pathways through cytoprotective, apoptotic and hypertrophic stimuli: a comparative study in adult cardiac myocytes. Cell Biochem Funct. 29:442–451. 2011. View Article : Google Scholar
28.	Jamnicki-Abegg M, Weihrauch D, Pagel PS, et al: Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology. 103:1006–1014. 2005. View Article : Google Scholar : PubMed/NCBI
29.	Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, et al: Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol. 294:H724–H735. 2008. View Article : Google Scholar : PubMed/NCBI
30.	Guo WP, Fu XG, Jiang SM and Wu JZ: Neuregulin-1 regulates the expression of Akt, Bcl-2, and Bad signaling after focal cerebral ischemia in rats. Biochem Cell Biol. 88:649–654. 2010.PubMed/NCBI
31.	Sapia L, Palomeque J, Mattiazzi A and Petroff MV: Na⁺/K⁺-ATPase inhibition by ouabain induces CaMKII-dependent apoptosis in adult rat cardiac myocytes. J Mol Cell Cardiol. 49:459–468. 2010.
32.	Rosca AM, Matei C, Dragan E and Burlacu A: Cardiomyocyte apoptosis in ischaemia-reperfusion due to the exogenous oxidants at the time of reperfusion. Cell Biol Int. 36:1207–1215. 2012. View Article : Google Scholar : PubMed/NCBI
33.	Chatziantoniou C, Pauti MD, Pinet F, et al: Regulation of renin release is impaired after nitric oxide inhibition. Kidney Int. 49:626–633. 1996. View Article : Google Scholar : PubMed/NCBI
34.	Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res. 107:1058–1070. 2010. View Article : Google Scholar : PubMed/NCBI
35.	Zhou G, Li X, Hein DW, et al: Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J Am Coll Cardiol. 52:655–666. 2008. View Article : Google Scholar
36.	Varagic J, Ahmad S, Voncannon JL, et al: Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats. J Hypertens. 30:1766–1774. 2012.
37.	Lemmens K, Fransen P, Sys SU, et al: Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase. Circulation. 109:324–326. 2004. View Article : Google Scholar : PubMed/NCBI
38.	Sawyer DB and Caggiano A: Neuregulin-1β for the treatment of systolic heart failure. J Mol Cell Cardiol. 51:501–505. 2011.
39.	Rohrbach S, Niemann B, Silber RE and Holtz J: Neuregulin receptors erbB2 and erbB4 in failing human myocardium-depressed expression and attenuated activation. Basic Res Cardiol. 100:240–249. 2005. View Article : Google Scholar : PubMed/NCBI
40.	Lemmens K, Doggen K and De Keulenaer GW: Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation. 116:954–960. 2007. View Article : Google Scholar : PubMed/NCBI